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ours to shame. We may well find ourselves not the
teachers we thought we were, but students of those who
simply will not be stopped under circumstances that
would have stopped us long ago.
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Linking disease control programmes in rural Africa: a
pro-poor strategy to reach Abuja targets and millennium
development goals
David H Molyneux, Vinand M Nantulya
The effectiveness of programmes to tackle malaria could be improved by linking them to initiatives
to prevent other diseases
The global community has committed itself to halving
the morbidity and mortality from malaria worldwide
by 2010 through the Roll Back Malaria initiative (box).1
This goal was endorsed by the African heads of state at
a summit held in Abuja, Nigeria, in April 2000.2 The
leaders set three targets to achieve by 2005: 60% of
malaria patients to have prompt (within 24 hours of
malaria attack), affordable, and appropriate treatment;
60% of all pregnant women to have access to
preventive presumptive intermittent therapy; and 60%
of children under 5 years and pregnant women to be
sleeping under insecticide treated mosquito nets. How-
ever, progress is currently slow. We suggest how
progress could be increased through linking disease
control or elimination programmes under way in
Africa to malaria control programmes. These pro-
grammes, many of which are based on drug donations,
bring additional public health benefits to affected
populations such as reduced anaemia, improved nutri-
tion, better child growth and development, and higher
school attendance. Such a strategy would have a rapid
effect on malaria morbidity and mortality among
underserved populations.
Feasibility of targets
The tools for achieving the Abuja targets already
exist—namely, insecticides, bed nets, and highly
effective drugs. However, they are not being provided
fast enough to the people who need them. Most
malaria attacks are managed outside the formal health
service as an out of pocket expenditure in the poorest
countries.3–5 Indeed, because of the AIDS epidemic,
children with malaria may be orphans cared for by
their grandmothers. Thus, for many countries in
sub-Saharan Africa, assuring treatment within 24
hours after a malaria attack means that antimalarial
drugs have to be available at an affordable price and in
simple formulations from the lowest level of the
healthcare system—that is, informal care givers in rural
villages. It will not be easy for poor countries to reach
this target of prompt treatment, especially if the more
Further examples of programmes that could be linked with
malaria control are on bmj.com
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effective, but more expensive, artemisinin based
combination treatments are to be used. The donor
community, governments of recipient countries, and
the pharmaceutical industry need to redouble their
efforts to make this happen.
The target is equally challenging for intermittent
presumptive therapy for pregnant women. Antenatal
services are not readily accessible to pregnant women
in rural areas in sub-Saharan Africa, largely because of
household poverty and poor health infrastructure. A
high proportion of women that attend antenatal
services make one or just a few irregular visits, after
which they deliver their babies at home without the aid
of a qualified attendant.
The most effective approach to reducing morbidity
and mortality from malaria among the poor and hard
to reach populations in rural areas in Africa is to con-
trol the mosquito vector. Effective control of the
vectors should also reduce the selection pressure for
drug resistance against available drugs.6 Current
emphasis in vector control is on the use of insecticide
treated bed nets, with the aim of achieving 60% cover-
age. However, the approach recommended for
sub-Saharan Africa—a voucher scheme for pregnant
women—has had a slow uptake and may be insufficient
to meet the target.
Under the scheme, touted as an example of public-
private partnership, vouchers are given to pregnant
women attending antenatal services. The women can
use the vouchers to buy bed nets at local outlets at sub-
sidised prices. However, since a high proportion of
pregnant women in rural sub-Saharan Africa do not
attend antenatal services, the voucher scheme misses
them and their children. Moreover, malaria is a disease
of poverty. The women receiving the vouchers may not
be able to afford to pay for the nets, even at subsidised
prices, especially as they do not have control over the
use of the household resources.
To achieve the Abuja targets and the United
Nation’s millennium development goals, African coun-
tries will need novel and creative approaches to
increase access to preventive measures. Access to health
care by needy populations is a particular challenge.
Another approach
We believe that an effective way to increase use of bed
nets would be to link their distribution to other
community driven global health initiatives that have
similar requirements. This would improve access to
poor and hard to reach populations and potentially
save costs. It also offers the opportunity to extend other
public health benefits (such as mass de-worming,
immunisation, and provision of clean water) to hard to
reach rural populations. Table 1 gives some examples
of these initiatives.
The feasibility of our proposed strategy is shown by
a recent, albeit limited, experience that linked the
distribution of free nets to a measles vaccination cam-
paign in remote rural districts in Zambia and Ghana.7 8
Through the measles immunisation campaign, families
with children under 5 years old were readily targeted
for distribution of nets. The immunisation campaign
achieved the Abuja target for net coverage in one week.
Follow up after the campaign showed that coverage for
both the nets and measles vaccination in the poorest
quintile was as high as in the richest quintile, showing
that this approach can extend public health benefits to
poor populations.
Linking with lymphatic filariasis
For both programmatic and technical reasons, the glo-
bal programme to eliminate lymphatic filariasis lends
itself particularly well to linkage with malaria control
programmes. The programme aims to reach all
eligible individuals living in areas at risk of lymphatic
filariasis once a year to deliver single dose drugs. Many
of these areas are also affected by malaria (figure). The
programme ensures repeated access to entire popula-
tions and thereby makes it an ideal partner for other
programmes where yearly contact with hard to reach
populations is essential, such as distribution of insecti-
cide treated nets.
Roll Back Malaria strategies
• Providing prompt access to effective treatment,
especially in young children
• Preventing and controlling malaria during
pregnancy
• Promoting the use of insecticide treated mosquito
nets as a means of prevention
• Dealing effectively with malaria in emergency and
epidemic situations
Table 1 Health initiatives that could be combined with malaria control programmes
Onchocerciasis Lymphatic filariasis
Intestinal helminths/
schistosomiasis Measles Trachoma
Objective To establish within 12 years,
effective and self sustainable
community based ivermectin
treatment throughout endemic
areas in Africa
Elimination of lymphatic
filariasis as public health
problem by 2020
Reduce morbidity and
mortality; target school aged
children through regular
treatment
Global eradication Elimination of blindness due to
trachoma
Programme strategy
or intervention
Community directed treatment
with ivermectin
Annual drug treatment with
diethylcarbamazine plus
albendazole or albendazole plus
ivermectin in areas co-endemic
for onchocerciasis. Vector
control where appropriate
Mass chemotherapy through
community treatment and
school health programmes,
improve sanitation, health
education
High vaccination coverage of
susceptible people:
Catch up campaigns
Follow up campaigns
Surveillance
SAFE strategy (surgery,
antibiotics, face washing, and
environmental improvement—
clean water and sanitation)
Affected regions 19 countries in WHO’s
AFRO region
≥80 endemic countries in the
tropics
All developing countries in
tropics and subtropics;
schistosomiasis particularly in
Africa, South East Asia, and
parts of the Americas
All except Americas Global tropics
Further examples are available on bmj.com
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In addition to the opportunity for repeated access
to entire populations, technical similarities favour
strong linkages between programmes to eliminate
filariasis and control malaria. Lymphatic filariasis is
transmitted by mosquitoes, and in sub-Saharan Africa
and parts of the Pacific Anopheles species of mosquitoes
are vectors of both malaria and the filarial parasite
Wuchereria bancrofti.9 Vector control through insecti-
cide treated nets has also been shown to protect
against filariasis, although it is not part of the
recommended strategy to eliminate the disease.
Indeed, in East Africa and Papua New Guinea bed nets,
primarily deployed to prevent malaria, also greatly
decreased transmission of filariasis, even without being
impregnated with insecticide.10 11 Thus, joint control
programmes have clear potential for enhancing public
health benefits in rural communities in co-endemic
regions.
The use of albendazole in the filariasis programme
also reduces the anaemia caused by hookworm and
Trichuris infections (table 2). This in turn will affect the
anaemia associated maternal and infant and child
morbidity and mortality closely linked to malaria.13 14
In addition, Spiegel et al reported a reduction in
malaria episodes in children in Senegal who were not
infected with helminths.15 The degree of protection
conferred by a worm free status, estimated to be
10-fold, is equivalent to or greater than that conferred
by the sickle cell trait.16 This finding, although needing
to be repeated on a larger scale, suggests that filariasis
control programmes could also reduce morbidity and
mortality from malaria and helminth infection. Other
well documented effects of deworming include
improved nutritional status,17 better micronutrient
uptake, improved cognitive development of children,18
increased weight gain,17 improved physical fitness and
appetite,19 and increased school attendance.19 20
The donated drugs supporting the programme to
eliminate lymphatic filariasis (ivermectin from Merck
and Co and albendazole from GlaxoSmithKline21)
could become important incentives to communities for
participating in bed net utilisation programmes.
Uptake is likely to be even higher if the nets (preferably
long lasting, insecticide treated nets) could also be
given free to rural populations. Distributing free insec-
ticide treated nets to these populations will increase
their productivity, reduce out of pocket costs for treat-
ing malaria, and thereby help alleviate household pov-
erty. An economically empowered community may be
able thereafter to access other health services,
including replacement of nets. Reimpregnation of nets
with insecticide may also be increased if the
retreatments were provided alongside mass drug
administration programmes targeting lymphatic
filariasis, onchocerciasis, schistosomiasis, intestinal
parasites, and trachoma.
The broader public health value of insecticide
treated nets for controlling transmission of vector
borne infections has been amply shown not only in
malaria, but also for lymphatic filariasis,22 cutaneous
leishmaniasis,23 Chagas’ disease,24 and tick borne
relapsing fever. The nets also reduce nuisance insects
(Culex and Cimex bed bugs), which users often find the
most value.
Making linkage work
Linkage of programmes to control individual diseases
would provide greater health benefits at reduced costs
to the healthcare system. The companies that
manufacture drugs for elimination of onchocerciasis,
filariasis, and trachoma have agreed to donate them for
as long as required. Programmes currently focused on
single diseases should now create linkages at national,
district, and community level. Community workers
already trained through complementary initiatives,
such as the polio eradication programme, could be
used for mass programmes to deliver drugs to treat
filariasis and distribute insecticide treated nets. For
instance, in the first annual mass drug administration
in Zanzibar in 2001, over 4000 community workers,
initially trained through other programmes, reached
76% of the 800 000 target population at risk of
lymphatic filariasis in a well planned, single day, door
to door campaign. Linking distribution of nets to such
a campaign would deliver on the Abuja targets for cov-
erage and also meet other health related millennium
development goals.
Such integrated distribution strategies also reduce
operational costs. The average cost for the delivery of
free nets when linked to a measles campaign was $3.74
(£2.07, €3.11) for each net delivered, of which $3.42
was for the cost of a net, and only $0.32 for distribution
logistics.25 These are among the lowest figures
documented in Africa.
Table 2 Broad antiparasite effectiveness (%) of single dose of
drugs used to control lymphatic filariasis12
Ivermectin Albendazole
Ascaris 100 100
Strongyloides 95 45
Enterobius 85 85
Trichuris 10-50 40-60
Hookworm 0-20 95
Larva migrans 100 80
Onchocerca 95 —
Lice 100 —
Scabies 100 —
Albendazole is also effective against cysticercosis, hydatids, Giardia,
trichomonads, Microsporidia, and Cryptosporidia but requires more than one dose.
Further resources
• Roll Back Malaria www.rbm.who.int
• International Federation of Red Cross and Red
Crescent Societies www.ifrc.org
• Global Initiative to Eliminate Filariasis
www.filariasis.org
• Filariasis.net http://filariasis.net
• International Trachoma Initiative www.trachoma.org
• African Programme for Onchocerciasis Control
www.who.int/ocp/apoc
• Regional Program for the Elimination of
Onchocerciasis www.iadb.org/EXR/doc97/apr/
rg4610e.htm
• Global Fund to Fight HIV/AIDS, Tuberculosis and
Malaria www.theglobalfund.org
• Schistosomiasis Control Initiative www.schisto.org
• Partnership for Child Development
www.child-development.org
• Partners for Parasite Control www.who.int/
wormcontrol/en
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Conclusions
A proactive pro-poor strategy linking well funded
malaria control programmes to other community
directed health initiatives, such as elimination of
lymphatic filariasis, onchocerciasis, schistosomiasis, or
trachoma and childhood immunisation, could greatly
accelerate progress towards achieving the Abuja
targets. These health initiatives, focused largely on full
community participation, offer other public health
benefits to the poorest and hardest to reach
populations. The current financing mechanism
through the Global Fund to Fight AIDS, Tuberculosis,
and Malaria encourages broad partnerships at all
levels and emphasises country ownership of the design
and implementation of intervention programmes.
This presents opportunities both for public health
dialogue and for cooperation between programmes
at national, district, and community levels. We urge
a shift in malaria control strategies to maximise
opportunities for bringing improved health to
vulnerable communities.
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Summary points
The global community has committed to halving
mortality from malaria by 2010
Current strategies focus on prompt access to
treatment, presumptive treatment for pregnant
women, and use of insecticide treated bed nets
Distribution of nets to hard to reach poor
populations could be accelerated by linking it to
programmes to control other disease
Such linkages offer other health benefits that
could also have a positive effect on morbidity
from malaria and enable Abuja targets to be
achieved
Current Global Fund financing mechanisms
present unique opportunities for dialogue and
cooperation between programmes at all levels
Endpiece
Deafness makes you depressed
[A]nd in the next year [1690] he [Anthony a
Wood] found a deafness, first in his right, and
afterwards in his left, eare, which continued more
or less till death. This disaster he look’d upon as the
first and greatest misery of his life. It made him
exceeding melancholy and more retir’d; was also at
great charg in taking physick and slops, to drive the
noises out of hie ears, and Dr John Lamphire took
a great deal of paines about them, but in vaine.
The life and times of Anthony A Wood.
Oxford: Oxford University Press, 1961:181
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